Showing results (1161-1170 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|August 23, 2012
Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degenerationYouxin Chen, Fei HanTherapeutics and Clinical Risk Management|June 16, 2012
Prevention and management of accidental foreign body ingestion and aspiration in orthodontic practiceUday Kumar Umesan, Kui Lay Chua, Priya BalakrishnanTherapeutics and Clinical Risk Management|July 7, 2012
Duloxetine in the management of chronic musculoskeletal painHoward S Smith, Eric J Smith, Benjamin R SmithTherapeutics and Clinical Risk Management|July 7, 2012
Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical collegePrerna Upadhyaya, Vikas Seth, Vijay V Moghe, et al.Therapeutics and Clinical Risk Management|February 6, 2015
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysisYing Huang, Ji-Feng Feng, Jin-Shi Liu, et al.Therapeutics and Clinical Risk Management|February 13, 2015
Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigationYuxiu Liu, Yufang Gao, Lili Wei, et al.Therapeutics and Clinical Risk Management|January 23, 2015
Tapentadol extended release in the management of peripheral diabetic neuropathic painNalini Vadivelu, Alice Kai, Benjamin Maslin, et al.Therapeutics and Clinical Risk Management|September 22, 2021
Lipid-Free PN is Associated with an Increased Risk of Hyperbilirubinemia in Surgical Critically Ill Patients with Admission Hepatic Disorder: A Retrospective Observational StudyShih-Chi Wu, Te-An Chen, Han-Tsung Cheng, et al.Therapeutics and Clinical Risk Management|October 2, 2018
Krait envenomation in ThailandAchara Tongpoo, Charuwan Sriapha, Aimon Pradoo, et al.Therapeutics and Clinical Risk Management|September 15, 2018
The effects of AER and eGFR on outcomes of CVD in patients with T2DM in an urban community over 8 years of multifactorial treatment: the Beijing Communities Diabetes Study 18Xue-Lian Zhang, Ming-Xia Yuan, Gang Wan, et al.Pageof 256